Mental Health

Female-led EverBlume Launches with a Mission to Support 40 Million Americans Struggling with Substance Abuse

Woman-led mental health platform EverBlume recently made its debut, positioning itself as an essential sobriety resource for individuals grappling with alcohol-related issues. At a time when substance abuse is rampant — with roughly 40 million Americans aged 12 and up needing treatment for substance abuse disorders in 2020 — resources have become increasingly scarce. EverBlume is stepping up to remedy this gap…

FDA Approves First Oral Treatment for Postpartum Depression

The U.S. Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a healthcare provider in certain healthcare…

SKYLARK Trial Unveils Promising Oral Therapy for Postpartum Depression

The SKYLARK Study, conducted by The Feinstein Institutes for Medical Research at Northwell Health, has shown promising results in treating postpartum depression (PPD). Led by Dr. Kristina M. Deligiannidis, the trial evaluated the efficacy of an investigational oral neuroactive steroid, zuranolone (50mg). The findings suggest zuranolone could become the first oral, at-home therapy approved by the FDA for PPD. The study included…

Big Health Acquires Limbix to Address the Adolescent Mental Health Crisis

San Francisco-based digital therapeutics leader, Big Health, is taking on the growing youth mental health crisis by acquiring Limbix, a company specializing in evidence-based digital therapeutics for adolescents and young adults with depression symptoms. The move expands Big Health’s therapeutic portfolio, which previously focused on insomnia and anxiety treatments for adults. The COVID-19 pandemic has exacerbated the mental health crisis among young…

New Study by EXHALE Reveals Scarcity of Culturally-Responsive Self-Care Tools for Black Women

EXHALE, an emotional well-being app for Black Women and Women of Color, has released a new report highlighting the insufficient number of self-care resources specifically created for Black Women. “The State of Self-Care for Black Women” report offers insights into the stress, racial trauma, and enduring the stereotype of strength that impacts Black Women’s mental, emotional, and physical health. Surveying 1,005 Black…

Anise Health Raises $1.2M to Expand Culturally-Responsive Mental Health Care for People of Color

Anise Health, a digital mental health platform designed to provide culturally-responsive mental health care for people of color, has successfully closed a pre-seed funding round worth $1.2 million, led by Kicker Ventures. Other investors include Gold House Ventures, Allston Venture Fund, and a range of strategic angel investors. Anise Health was founded by Harvard grads Alice Zhang and Nisha Desai in 2022.…

Female-led Virtual Neurology Clinic Neura Health Adds $8M in Seed Funding

Virtual neurology clinic Neura Health has raised $8M in seed funding to expand its go-to-market approach and bring its neurology care offerings to the enterprise sector. The funding round was led by Koch Disruptive Technologies and Norwest Venture Partners, with participation from Pear VC, Next Play Ventures, Correlation Ventures, and Plug and Play Ventures. This latest financing round builds upon Neura’s $2.M…

Menopause Platform Gennev Partners with LifeStance to Expand Its Mental Health Offering

We last talked about menopause startup Gennev last October when menopause startup Gennev was acquired by Unified Women’s Health, a company that operated, affiliates, and invests in women’s health businesses. Now the company is back with some partnership news as it expands the scope of is platform. During perimenopause and menopause, women often experience emotional health challenges, including depression and anxiety. Recognizing…